Cargando…

Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence

BACKGROUND: The use of laboratory-expanded mesenchymal stem cells (MSCs) is subject to several restrictions, resulting in “minimal manipulation” methods becoming the current most popular strategy to increase the use of MSCs in an orthopaedic practice. The aim of the present systematic review is to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Matteo, B., Vandenbulcke, F., Vitale, N. D., Iacono, F., Ashmore, K., Marcacci, M., Kon, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710724/
https://www.ncbi.nlm.nih.gov/pubmed/31485234
http://dx.doi.org/10.1155/2019/1735242
_version_ 1783446395388166144
author Di Matteo, B.
Vandenbulcke, F.
Vitale, N. D.
Iacono, F.
Ashmore, K.
Marcacci, M.
Kon, E.
author_facet Di Matteo, B.
Vandenbulcke, F.
Vitale, N. D.
Iacono, F.
Ashmore, K.
Marcacci, M.
Kon, E.
author_sort Di Matteo, B.
collection PubMed
description BACKGROUND: The use of laboratory-expanded mesenchymal stem cells (MSCs) is subject to several restrictions, resulting in “minimal manipulation” methods becoming the current most popular strategy to increase the use of MSCs in an orthopaedic practice. The aim of the present systematic review is to assess the clinical applications of “minimally” manipulated MSCs, either as bone marrow aspirate concentrate (BMAC) or as stromal vascular fraction (SVF), in the treatment of knee osteoarthritis (OA). METHODS: A systematic review of three databases (PubMed, ScienceDirect, and Google Scholar) was performed using the following keywords: “Knee Osteoarthritis” with “(Bone marrow aspirate) OR (bone marrow concentrate)” or with “(adipose-derived mesenchymal stem cells) OR (adipose derived stromal cells) OR (stromal vascular fraction) OR (SVF)” as either keywords or MeSH terms. The reference lists of all retrieved articles were further reviewed for identification of potentially relevant studies. RESULTS: Twenty-three papers were included in the final analysis (10 on BMAC and 13 on SVF). Of these, only 4 were randomized controlled trials (RCTs). Bias risk evaluation, performed using a modified Coleman score, revealed an overall poor quality of the studies. In terms of clinical application, despite the apparent safety of minimally manipulated MSCs and the short-term positive clinical outcomes associated with their use, clinicians reported different preparation and administration methods, ranging from single intra-articular injections to intraosseous applications to administration in combination with other surgical procedures. CONCLUSIONS: The available literature is undermined by both the lack of high-quality studies and the varied clinical settings and different protocols reported in the few RCTs presently published. This prevents any recommendation on the use of either product in a clinical practice. Nevertheless, the use of minimally manipulated MSCs (in the form of BMAC or SVF) has been shown to be safe and have some short-term beneficial effects.
format Online
Article
Text
id pubmed-6710724
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67107242019-09-04 Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence Di Matteo, B. Vandenbulcke, F. Vitale, N. D. Iacono, F. Ashmore, K. Marcacci, M. Kon, E. Stem Cells Int Review Article BACKGROUND: The use of laboratory-expanded mesenchymal stem cells (MSCs) is subject to several restrictions, resulting in “minimal manipulation” methods becoming the current most popular strategy to increase the use of MSCs in an orthopaedic practice. The aim of the present systematic review is to assess the clinical applications of “minimally” manipulated MSCs, either as bone marrow aspirate concentrate (BMAC) or as stromal vascular fraction (SVF), in the treatment of knee osteoarthritis (OA). METHODS: A systematic review of three databases (PubMed, ScienceDirect, and Google Scholar) was performed using the following keywords: “Knee Osteoarthritis” with “(Bone marrow aspirate) OR (bone marrow concentrate)” or with “(adipose-derived mesenchymal stem cells) OR (adipose derived stromal cells) OR (stromal vascular fraction) OR (SVF)” as either keywords or MeSH terms. The reference lists of all retrieved articles were further reviewed for identification of potentially relevant studies. RESULTS: Twenty-three papers were included in the final analysis (10 on BMAC and 13 on SVF). Of these, only 4 were randomized controlled trials (RCTs). Bias risk evaluation, performed using a modified Coleman score, revealed an overall poor quality of the studies. In terms of clinical application, despite the apparent safety of minimally manipulated MSCs and the short-term positive clinical outcomes associated with their use, clinicians reported different preparation and administration methods, ranging from single intra-articular injections to intraosseous applications to administration in combination with other surgical procedures. CONCLUSIONS: The available literature is undermined by both the lack of high-quality studies and the varied clinical settings and different protocols reported in the few RCTs presently published. This prevents any recommendation on the use of either product in a clinical practice. Nevertheless, the use of minimally manipulated MSCs (in the form of BMAC or SVF) has been shown to be safe and have some short-term beneficial effects. Hindawi 2019-08-14 /pmc/articles/PMC6710724/ /pubmed/31485234 http://dx.doi.org/10.1155/2019/1735242 Text en Copyright © 2019 B. Di Matteo et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Di Matteo, B.
Vandenbulcke, F.
Vitale, N. D.
Iacono, F.
Ashmore, K.
Marcacci, M.
Kon, E.
Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence
title Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence
title_full Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence
title_fullStr Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence
title_full_unstemmed Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence
title_short Minimally Manipulated Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence
title_sort minimally manipulated mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review of clinical evidence
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710724/
https://www.ncbi.nlm.nih.gov/pubmed/31485234
http://dx.doi.org/10.1155/2019/1735242
work_keys_str_mv AT dimatteob minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence
AT vandenbulckef minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence
AT vitalend minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence
AT iaconof minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence
AT ashmorek minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence
AT marcaccim minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence
AT kone minimallymanipulatedmesenchymalstemcellsforthetreatmentofkneeosteoarthritisasystematicreviewofclinicalevidence